期刊文献+

子宫内膜腺鳞癌51例临床预后分析 被引量:3

Clinical analysis of 51 cases with adenosquamous carcinoma of the endometrium
下载PDF
导出
摘要 目的通过对子宫内膜腺鳞癌临床特征的分析,探讨影响预后的因素。方法回顾性研究1997年7月至2007年5月湖南省肿瘤医院共收治51例子宫内膜腺鳞癌病人。结果①腺鳞癌占同期全部宫内膜癌的4.78%,腹膜后淋巴结转移率14.0%。②肌层浸润〈1/2与〉1/2的宫外转移率分别为26%和62.5%,差异具有显著性(P〈0.05)。③单因素线性回归分析显示:腺癌分化程度与浸润肌层深度有关(P=0.035)。④Ⅰ期5a生存率85.7%,Ⅲ期5a生存率66.7%,而Ⅳ期2a生存率分别为33.3%。结论子宫内膜腺鳞癌临床特征与普通子宫内膜样腺癌无明显区别。分化程度和肌层浸润深度是影响其预后的重大因素。 Objective To study the clinical characteristics and prognosis for adenosquamous carcinoma of the endometrium. Methods 51 cases with pathologically confirmed endometrium adenosquamous carcinoma from Jan 1997 to May 2007 were retrospectively analyzed. Results Among the endometrium adnocarcinoma patients, 4.78% were adenosquamous carcinoma, lymph note metastases rate was 14.0%. Distant metastases who had deep myometrium infiltration and those who hadn't were 26% and 62.5%, respectively (P〈0.05). Linear-regression analysis showed pathologic grade of adenocarcinoma was correlated with depth of muscularis invasion (P=0.035). The 5-year overall survival was 85.7% in stage Ⅰ, 66.7% in stage Ⅲ while the 2-year overall survival was 33.3% of endometrium adenosquamous carcinoma in stage Ⅳ. Conclusions The clinical characters and prognosis of endometrium adenosquamous carcinoma might be similar to other endometrioid carcinomas. The pathologic grade and depth of muscularis invasion could be important factors which affect the prognosis.
出处 《世界肿瘤杂志》 2009年第1期53-55,共3页 Tumour Journal of the World
关键词 子宫内膜肿瘤 腺鳞癌 治疗 预后 Endometrial carcinoma Adenosquamous carcinoma Prognosis
  • 相关文献

同被引文献25

  • 1房昭,杨爱莲,詹雪梅,魏继红.宫腔镜及CT/MR检查在诊断子宫内膜癌宫颈受累中的价值[J].中华临床医师杂志(电子版),2010,4(7):966-970. 被引量:11
  • 2Pecorelli S.Revised FIGO staging for carcinoma of the vulva,cervix,and endometrium[J].Int J Gynecol Obstet,2009,105(2):103104.
  • 3Pekin T,Yildizhan B,Eren F,et al.Adenocarcinoma,adenoacanthoma,and mixed adenosquamous carcinoma of theendometrium[J].Eur J Gynecol Oncol,2001,22(2):151-153.
  • 4连丽娟,林巧稚.妇科肿瘤学[M].4版.北京:人民卫生出版社,2006:514-516.
  • 5丰有吉,沈铿.妇产科学[M].北京:人民卫生出版社,2006:357.
  • 6曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2005:2600.
  • 7Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[J]. Int J Gynecol Obstet, 2009,105 (2): 103-104.
  • 8Pekin T, Yildizhan B, Eren F, et al.Adenocarcinoma, adenoacan- thoma, and mixed adenosquamous carcinoma of the endometrium [J].Eur J Gynecol Oncol,2010,22(2) : 151-153.
  • 9Mendivll A, Schuler M, Gehrig A. Non endometrloid adenocarcininoma of the uterine corpus: areview of selected histological subtypes [J]. cancer control, 2009, 16 ( 1 ) : 46 -52.
  • 10Viswanathan AN , MacklinEA , importance of chemotherapy and Brekowitz R , et al . The radiation in uterine papillary serous carcinoma [J]. Gynecol Oncol, 2011, 123 (3): 542 - 547.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部